Page last updated: 2024-09-03

dx 9065 and amprenavir

dx 9065 has been researched along with amprenavir in 1 studies

Compound Research Comparison

Studies
(dx 9065)
Trials
(dx 9065)
Recent Studies (post-2010)
(dx 9065)
Studies
(amprenavir)
Trials
(amprenavir)
Recent Studies (post-2010) (amprenavir)
17005559194

Protein Interaction Comparison

ProteinTaxonomydx 9065 (IC50)amprenavir (IC50)
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (BRU ISOLATE)0.027
Gag-Pol polyproteinHuman immunodeficiency virus type 2 (ISOLATE ROD)0.0026
Gag polyproteinHIV-1 M:B_MN0.013
Cytochrome P450 3A4Homo sapiens (human)1
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.0558
Thromboxane-A synthase Homo sapiens (human)6.727
Protease Human immunodeficiency virus 10.1553

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1

Reviews

1 review(s) available for dx 9065 and amprenavir

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000